Friday, April 21, 2017

Hepatitis C - DAAs may impact inflammatory markers in cirrhosis, HCC surveillance

Meeting Coverage Healio

DAAs may impact inflammatory markers in cirrhosis, HCC surveillance
April 21, 2017
AMSTERDAM — Curing patients with cirrhosis of hepatitis C virus could alter the inflammatory milieu and have an impact on the way CD8+ T-cells surveil potential carcinoma, according to data presented at the International Liver Congress.

“Interferon-free cure of HCV alters the inflammatory milieu, which could impact HCC,” Solomon Owusu Sekyere, MD, of the department of gastroenterology, hepatology and endocrinology, at Hannover Medical School, Hannover, 3TTU-IICH and the German Center for Infectious Diseases in Hannover-Braunschweig, Germany, said during his presentation. “HCC occurrence after HCV clearance is still conflicting.”

International Liver Congress™ 2017
Updates On This Blog

No comments:

Post a Comment